Unknown PHASE2 INTERVENTIONAL NCT00320294

ILF With/Without Cisplatin for Advanced Gastric Cancer

A Randomized Trial of Irinotecan, Leucovorin, 5-FU (ILF) Versus ILF Plus Cisplatin (PILF) Combination Chemotherapy in Patients With Advanced Gastric Cancer

Sponsor: Gachon University Gil Medical Center

Conditions Stomach Neoplasm

Interventions cisplatin irinotecan

Updated 6 times since 2017 Last updated: Mar 9, 2007 Started: Feb 28, 2005 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00320294, this PHASE2 trial focuses on Stomach Neoplasm and remains ongoing. Sponsored by Gachon University Gil Medical Center, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gachon University Gil Medical Center

Data source: Gachon University Gil Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Incheon, South Korea